CAS 22467-07-8: (3beta,16beta,21beta,22alpha)-olean-12-ene-3,16,21,22,23,28-hexol

Gymnemagenin is a bioactive compound, specifically a saponin, which is extracted from the leaves of Gymnema sylvestre, a plant native to the forests of India and Africa. This plant has been extensively studied due to its wide range of pharmacological effects, primarily involving its role in metabolic regulation. The mode of action of Gymnemagenin involves its interaction with glucose metabolism pathways. It is known to influence the activity of various enzymes and receptors that are crucial for glucose uptake and utilization. By modulating taste perception and enhancing insulin activity, Gymnemagenin has a direct impact on blood sugar levels, making it a focal point for diabetes research. Gymnemagenin is predominantly used in scientific studies focused on developing therapeutic interventions for diabetes mellitus and other metabolic disorders. Its ability to regulate carbohydrate metabolism is of particular interest for researchers looking for natural alternatives in the management of high-blood-sugar conditions. Additionally, its potential effects on lipid profiles and weight management are being investigated, offering broader insights into its applicability in metabolic health research.

Cyclic alcohol

Gymnemagenin

Gymnemagenin is a potent and selective antagonist for the β isoform of LXR, it has antihyperglycemic activity.

Other cyclanic, cyclenic or cycloterpenic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives